US trade action threatens Brazilian AIDS programme

BMJ 2001; 322 doi: http://dx.doi.org/10.1136/bmj.322.7283.383 (Published 17 February 2001)
Cite this as: BMJ 2001;322:383.1

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gavin Yamey
  1. BMJ

    International health agencies have condemned the US government for threatening the Brazilian policy of providing free drugs to patients infected with HIV.

    The US government has initiated legal proceedings against Brazil, through the World Trade Organisation's dispute settlement body, claiming that Brazil's production of generic HIV drugs breaks international laws on patent protection.

    Brazilian laws provide patent protection to foreign drug companies if they manufacture their product in Brazil. These laws have allowed local Brazilian companies to manufacture generic HIV drugs at low cost. The United States has complained to the World Trade Organisation that this requirement for local production discriminates against the US …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL